Monocytes inhibit NK activity via TGF-ß in patients with obstructive sleep apnoea Source: Eur Respir J, 49 (6) 1602456; 10.1183/13993003.02456-2016 Year: 2017
Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea Source: Eur Respir J 2011; 37: 89-97 Year: 2011
Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Source: Eur Respir J 2009; 33: 793-796 Year: 2009
Activated CD8 T-lymphocytes in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 820-828 Year: 2005
Bronchial inflammation in obstructive sleep apnea (OSA) patients Source: Eur Respir J 2003; 22: Suppl. 45, 466s Year: 2003
NKT cells in systemic inflammation in the obstructive sleep apnoea syndrome (OSAS) Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015
Selective activation of pro-inflammatory cytokines in obstructive sleep apnoea syndrome and impact of CPAP Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Upper airway and systemic inflammation in obstructive sleep apnoea Source: Eur Respir J 2016; 48: 1108-1117 Year: 2016
The vascular micromilieu in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 780-782 Year: 2005
Pathophysiology of OSA Source: Eur Respir Mon 2010; 50: 31-50 Year: 2010
Obstructive sleep apnoea and COPD Source: Eur Respir Mon 2013; 59: 135-143 Year: 2013
Relationship between upper airway inflammation and systemic inflammation in obstructive sleep apnoea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
The role of angiogenesis in obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005
Local airway inflammation in obstructive sleep apnoea: the role of leptin Source: Eur Respir J 2006; 28: Suppl. 50, 645s Year: 2006
Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? Source: Eur Respir J 2012; 39: 1547-1549 Year: 2012
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
Production of TNF-α, MMPs, and MCP-1 by monocytes and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
The difference in obstructive sleep apnoea symptoms between patients with obstructive and inflammatory diseases Source: Eur Respir J 2005; 26: Suppl. 49, 65s Year: 2005